Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.9B | $2.83B | +2.46% |
Gross Profit | $1.72B | $1.69B | +1.72% |
Net Income | $583.43M | $610.84M | -4.49% |
EPS (Basic) | $28.20 | $28.69 | -1.71% |
EPS (Diluted) | $28.12 | $28.55 | -1.51% |
R&D Expense | $146.77M | $139.3M | +5.36% |
SG&A Expense | $738.49M | $698.96M | +5.65% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.52B | $3.32B | +6.07% |
Current Assets | $1.28B | $1.2B | +6.92% |
Total Liabilities | $3.77B | $3.47B | +8.53% |
Current Liabilities | $1.19B | $1.18B | +0.60% |
Stockholders' Equity | $-249.2M | $-154.35M | -61.45% |
Cash & Equivalents | $69.06M | $71.57M | -3.51% |
Long-Term Debt | $2.15B | $1.89B | +13.46% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $730.19M | $702.16M | +3.99% |
Investing Cash Flow | $-153.47M | $-68.41M | -124.34% |
Financing Cash Flow | $-563.04M | $-632.28M | +10.95% |
Share Buybacks | $656.25M | $637.5M | +2.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 59.2% | 59.6% | -0.43% |
Net Margin | 20.1% | — | — |
ROE | -234.1% | — | — |
ROA | 16.6% | — | — |
Current Ratio | $1.075 | — | — |
Debt to Equity | $-15.131 | — | — |
Other companies in Life Sciences Tools & Services